开放与腹腔镜胰腺切除术的成本效益:一项全国性人群研究
该研究基于韩国国民健康保险服务2016至2018年9256例接受胰十二指肠切除术(66.8%)和远端胰腺切除术(33.2%)的患者数据,比较腹腔镜与开放胰腺切除术的成本效益。结果显示,除胰十二指肠切除术的住院期间费用较高外,腹腔镜胰腺切除术对两种术式均是具有成本效益的替代方案。
要点
- 腹腔镜胰腺切除术在胰十二指肠切除术中占12.4%,在远端胰腺切除术中占53.4%。
- 胰十二指肠切除术中,腹腔镜较开放手术增量成本效益比为住院期间每质量调整生命年147429美元,1年为每质量调整生命年-614965美元。
- 远端胰腺切除术中,腹腔镜较开放手术增量成本效益比为住院期间每质量调整生命年-94519美元,1年为每质量调整生命年-206351美元。
核心结论
- 腹腔镜胰腺切除术是开放胰腺切除术在胰十二指肠切除术和远端胰腺切除术中具有成本效益的替代方案,但胰十二指肠切除术的住院期间费用较高。
研究设计与样本
- 基于韩国国民健康保险服务2016至2018年9256例接受胰腺切除术患者数据的全国性人群研究,其中胰十二指肠切除术占66.8%,远端胰腺切除术占33.2%。
主要发现
- 胰十二指肠切除术中,腹腔镜胰腺切除术较开放胰腺切除术住院期间增加0.0022质量调整生命年,1年增加0.0023质量调整生命年。
- 胰十二指肠切除术中,腹腔镜胰腺切除术较开放胰腺切除术增量成本为住院期间321美元,1年为-1414美元。
- 胰十二指肠切除术中,腹腔镜胰腺切除术较开放胰腺切除术增量成本效益比为住院期间每质量调整生命年147429美元,1年为每质量调整生命年-614965美元。
- 远端胰腺切除术中,腹腔镜胰腺切除术较开放胰腺切除术住院期间改善0.0131质量调整生命年,住院期间改善0.0285质量调整生命年。
- 远端胰腺切除术中,腹腔镜胰腺切除术较开放胰腺切除术增量成本为住院期间-1240美元,1年为-5875美元;增量成本效益比为住院期间每质量调整生命年-94519美元,1年为每质量调整生命年-206351美元。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Laparoscopic pancreatic resection is comparable to open pancreatic resection; however, cost-effectiveness analyses of laparoscopic pancreatic resection are scarce. The authors performed a population-based study investigating the cost-effectiveness of laparoscopic pancreatic resection versus open pancreatic resection. METHODS: Data from 9,256 patients who received pancreaticoduodenectomy (66.8%) and distal pancreatectomy (33.2%) from 2016 to 2018 were retrieved from the Korean National Health Insurance Service. Events after pancreatectomy were categorized as no complication, complication, and death. Probabilities of each event and average cost during index admission and 1 year were utilized to calculate incremental cost-effectiveness ratio, the cost difference between two interventions divided by quality-adjusted life year. Quality-adjusted life year, a function of length and quality of life, was measured with utility values determined by researching literature. RESULTS: Laparoscopic pancreatic resection was performed in 12.4% of pancreaticoduodenectomies and 53.4% of distal pancreatectomies. For pancreaticoduodenectomy, laparoscopic pancreatic resection was associated with an increase of 0.0022 quality-adjusted life years for index admission and 0.0023 quality-adjusted life years for 1 year compared with open pancreatic resection. The incremental cost was $321 for index admission and -$1,414 for 1 year, leading to an incremental cost-effectiveness ratio of $147,429 per quality-adjusted life year gained for index admission and -$614,965 per quality-adjusted life year gained for 1 year. For distal pancreatectomy, laparoscopic pancreatic resection improved 0.0131 quality-adjusted life years for index admission and 0.0285 quality-adjusted life years for index admission. The incremental cost was -$1,240 for index admission and -$5,875 for 1 year, leading to an incremental cost-effectiveness ratio of -$94,519 per quality-adjusted life year gained for index admission and -$206,351 for 1 year. CONCLUSION: laparoscopic pancreatic resection was a cost-effective alternative to open pancreatic resection for pancreaticoduodenectomy and distal pancreatectomy, except for the higher cost of index admission for pancreaticoduodenectomy.
引用
- Lee JS, Oh HL, Yoon YS, et al. Cost-effectiveness of open versus laparoscopic pancreatectomy: A nationwide, population-based study. Surgery. 2024. PMID: 38772778. doi:10.1016/j.surg.2024.03.046
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。